Yes, approximately. In fact, that's an account of list prices. If you looked at comparator countries, high-income countries with universal health care systems, Canada is probably one of the highest price-paying markets for pharmaceuticals even after you account for the negotiations that our provinces undertake. That's because a significant proportion of our medicines are purchased by private insurers or by uninsured Canadians, both of which have little or no negotiating power with manufacturers.
